IN RE: GENERIC PHARMACEUTICALS PRICING ANTITRUST LITIGATION
Case Number:
2:16-md-02724
Court:
Nature of Suit:
Multi Party Litigation:
Class Action, Multi-district Litigation
Judge:
Firms
- Skadden Arps
- Winston & Strawn
- Norton Rose
- Sarraf Gentile
- Burns Charest
- Lewis Brisbois
- Kabat Chapman
- WilmerHale
- Greenberg Traurig
- Tarter Krinsky
- Gustafson Gluek
- Fiddler Gonzalez
- McCune Law
- Kirkland & Ellis
- Patterson Belknap
- Goodwin Procter
- Ahern and Associates
- Tostrud Law Group
- Morgan Lewis
- Manatt Phelps
- Kasowitz Benson
- Spiro Harrison
- Harkins Cunningham
- Larson King
- Axinn Veltrop
- Kaplan Fox
- Reed Smith
- Cozen O'Connor
- Buchanan Ingersoll
- Robbins Geller
- Freshfields
- Pashman Stein
- McDermott Will & Schulte
- Levin Sedran
- Armstrong Teasdale
- Dilworth Paxson
- Cleary Gottlieb
- Blank Rome
- Gross & Belsky
- Hogan Lovells
- Arnold & Porter
- Obermayer Rebmann
- Faegre Drinker
- Sills Cummis
- Lowenstein Sandler
- Zuckerman Spaeder
- Vinson & Elkins
- DLA Piper
- DiCello Levitt
- Tycko & Zavareei
- Freedman Boyd
- Earp Cohn
- Steyer Lowenthal
- Zelle LLP
- Cera LLP
- Garwin Gerstein
- Girard Sharp
- Wilson Sonsini
- Krantz & Berman
- Cole Schotz
- White & Case
- Lockridge Grindal
- Proskauer Rose
- Troutman
- Debevoise & Plimpton
- Linklaters LLP
- Baker Botts
- Grabar Law
- Rosenn Jenkins
- Barrack Rodos
- Fox Rothschild
- Anselmi & Carvelli
- Pogust Goodhead
- Cuneo Gilbert
- Stradley Ronon
- Welsh & Recker
- DeCotiis FitzPatrick
- Berry Law LLC
- NastLaw
- Pendley Baudin
- Zwerling Schachter
- Rule Garza
- Joseph Saveri Law Firm
- Competition Law Partners
- Seeger Weiss
- Barrett Law Group
- McConnell Valdes
- Saiber LLC
- Hausfeld LLP
- Gordon Rees
- Paul Weiss
- Safirstein Law
- Neufeld Scheck
- Spector Roseman
- Edelson Lechtzin
- Goldman Scarlato
- Hach Rose Schirripa
- Faruqi & Faruqi
- Schertler Onorato
- Wiggin & Dana
- Shinder Cantor
- Wexler Boley
- Bailey & Glasser
- Royer Cooper
- Roberts Law Firm US
- Motley Rice
- Shapiro Arato
- Walsh Pizzi
- Stueve Siegel
- Boni Zack
- Segal McCambridge
- Venable LLP
- Lyden Chappell
- Andrus Anderson
- Duane Morris
- Hagens Berman
- Bonsignore Trial Lawyers
- Napoli Shkolnik
- Carella Byrne
- Kelley Drye
- McCracken Stemerman
- Boies Schiller
- Fenwick & West
- Williams & Connolly
- Polsinelli PC
- Kohn Swift
- King & Spalding
- Wisner Baum
- George Feldman
- Bailey Duquette
- Stevens & Lee
- Calcaterra Pollack
- Ballard Spahr
- Foley & Lardner
- Baker & Hostetler
- Francis Mailman
- Rosca Scarlato
- Weil Gotshal
- Gibson Dunn
- O'Melveny & Myers
- Nussbaum Law Group
- Morrison & Foerster
- Haynes Boone
- Schneider Wallace
- Steptoe LLP
- Lieff Cabraser
- Barnes & Thornburg
- Crowell & Moring
- Butler Reichline
- Dugan Law Firm
- Marks O'Neill
- Langer Grogan
- Law Offices of Francis O. Scarpulla
- Petrillo Klein
- Heins Mills
- Kralowec Law
- Furth Salem
- Hangley Aronchick
- Pullman & Comley
- Yarborough Law Firm
- Bartlit Beck
- Wolf Haldenstein
- Cotchett Pitre
- Lowey Dannenberg
- Steven Williams Law
- Taus Cebulash
- Bingham McCutchen
- Scott&Scott
- White and Williams
- Dechert LLP
- Seward & Kissel
- Hughes Hubbard
- Simpson Thacher & Bartlett LLP
- Miller & Chevalier
- Lite DePalma
- Berman Tabacco
- Radice Law Firm
- Whatley Kallas
- Cohen Milstein
- O’Neill & Borges
- Sperling Kenny
- Clark Hill
- Miller Shah
- Zimmerman Reed
- Berger Montague
- Susman Godfrey
- Glancy Prongay
- K&L Gates
- Alston & Bird
- Constantine Cannon
- Harris St. Laurent
- Shipman & Goodwin
- Fine Kaplan
- Grant & Eisenhofer
- Labaton Keller
- Haug Partners
- Saveri & Saveri
- Curtis Mallet-Prevost
- Latham & Watkins
Companies
- Albertsons Cos. Inc.
- J.M. Smith Corp.
- Walgreens Boots Alliance Inc.
- McKesson Corp.
- Perrigo Co. PLC
- Humana Inc.
- Impax Laboratories, Inc.
- Blue Cross Blue Shield Association
- MSP Recovery
- Endo International PLC
- Bausch Health Cos. Inc.
- Sandoz International GmbH
- Aurobindo Pharma Ltd.
- Dr. Reddy's Laboratories Ltd.
- The Harvard Drug Group LLC
- Lupin Ltd.
- Amneal Pharmaceuticals Inc.
- Sun Pharmaceutical Industries Ltd.
- Lannett Company, Inc
- Health Care Service Corp.
- Taro Pharmaceutical Industries Ltd.
- Bi-Lo
- The Cigna Group
- Cencora Inc.
- Glenmark Pharmaceuticals Ltd.
- Viatris Inc.
- Walmart Inc.
- Hi-Tech Pharmacal Co., Inc.
- Red Oak Sourcing LLC
- Molina Healthcare Inc.
- Allergan PLC
- Par Pharmaceutical Cos. Inc.
- Fougera Pharmaceuticals Inc.
- United Food & Commercial Workers International Union
- Alvogen Group Inc.
- West-Ward Pharmaceutical Corp.
- Cadila Pharmaceuticals Ltd.
- Ascend Laboratories LLC
- Emcure Pharmaceuticals Ltd.
- Florida Blue
- Aetna Inc.
- Akorn Inc.
- Cardinal Health Inc.
- Avet Pharmaceuticals Inc.
- Camber Pharmaceuticals Inc.
- Zydus Pharmaceuticals Inc.
- International Union Of Operating Engineers
- Centene Corp.
- G&W Laboratories Inc.
- The Kroger Co.
- Upsher-Smith Laboratories Inc.
- Rite Aid Corp.
- Winn-Dixie Stores, Inc.
- Wockhardt Ltd.
- Wockhardt USA LLC
- Pfizer Inc.
- Jubilant Cadista
- Novartis AG
- American Federation of State County & Municipal Employees
- Teva Pharmaceutical Industries Ltd.
Government Agencies
Sectors & Industries:
-
February 14, 2024
Settlements of 3 Drug Cos. Get Prelim OK In Price-Fixing MDL
A Pennsylvania federal judge granted preliminary approval Wednesday to settlements in which two makers and one distributor of generic drugs agreed to pay a combined $45 million to resolve allegations they colluded to fix the prices of medications, including those used to treat glaucoma, high blood pressure and high cholesterol.
-
February 01, 2024
State-Led Generic Drug Cases Removed From MDL
The Judicial Panel on Multidistrict Litigation has sent a trio of cases from state-level enforcers back to federal court in Connecticut, separating them from the sprawling MDL centralized in Pennsylvania over claims of price fixing in the generic drug industry.
-
January 23, 2024
3 Generic-Drug Cos. Reach Settlements In Price-Fixing MDL
Generic-drug makers Apotex Corp., Heritage Pharmaceuticals Ltd. and Breckenridge Pharmaceutical Inc. have each agreed to shell out a combined $45 million to settle allegations they colluded to fix the prices of many medications, according to a trio of motions filed Tuesday in multidistrict litigation in Pennsylvania federal court.
-
January 17, 2024
Generic-Drug Cos. Say States Are Mum In MDL Discovery
Generic-drug makers steeped in antitrust multidistrict litigation are asking for an order enforcing a months-old deadline for documents that most states have ignored, according to a memorandum filed in Pennsylvania federal court.
-
December 07, 2023
Generics Price-Fixing Cases Should Stay In MDL, Judge Says
The Pennsylvania federal judge overseeing sprawling multidistrict litigation against generic-drug makers on Thursday told the U.S. Judicial Panel on Multidistrict Litigation that she does not recommend transferring state enforcer actions out of the MDL yet, saying there's more the court can do to get the cases ready for trial or to tee up settlement talks.
-
November 02, 2023
States Want Generic Drug Price-Fixing Claims Back In Conn.
State enforcers accusing several generic drugmakers of price-fixing asked the Judicial Panel on Multidistrict Litigation to move their case back to Connecticut federal court, saying legislation signed by President Joe Biden last year spares state enforcers from the MDL process.
-
October 04, 2023
States Back Off Bid To Block Sandoz Spinoff In Antitrust Case
Novartis AG completed the planned spinoff of its Sandoz unit on Wednesday, after state enforcers and others withdrew their bid to block the move over concerns about recovering alleged overcharges from a sprawling conspiracy to fix generic drug prices.
-
September 29, 2023
States Ask To Block Sandoz Spinoff Over Price-Fixing Claims
State enforcers and others have asked a Pennsylvania federal court to halt Novartis AG's planned spinoff of its Sandoz unit, saying the move could stop them from recovering overcharges from the company for a sprawling conspiracy to fix generic drug prices.
-
August 17, 2023
DOJ Wants Equal Access To Docs in Ex-Exec's Criminal Case
The U.S. Department of Justice has urged a Pennsylvania federal judge to deny a former Taro Pharmaceutical executive's bid to use material from multidistrict litigation over alleged generic drug price-fixing to defend himself in a related criminal case, arguing the request would create an unfair advantage since the court previously rejected a similar ask from the government.
-
May 23, 2023
DOJ, Drug Buyers Rip Teva's Criminal Probe Doc Bid In MDL
The government and drug buyers fired back in separate filings in Pennsylvania federal court Tuesday against Teva's bid to use material from a criminal investigation into alleged generic drug price-fixing to defend itself in parallel civil multidistrict litigation over similar allegations, arguing it would undermine prosecutions and create a procedural "mess."